Kumar Anil, Dogra Samrita
Pharmacology Division, University Institute of Pharmaceutical Sciences, Panjab University, Chaindigarh, India.
Drugs Today (Barc). 2008 Oct;44(10):757-66. doi: 10.1358/dot.2008.44.10.1265487.
Strokes, or brain attacks, which occur due to an interruption of blood flow in discrete regions of the brain, are a major cause of death. Stroke is the third leading cause of death and disability in developed nations. The complex pathophysiology of this medical problem includes excitotoxicity mechanisms, inflammatory pathways, oxidative damage and ionic imbalances. The final event is the ischemic neuronal death which results in an irreversible loss of the neuronal function. Recently, significant therapeutic advances have been made which include use of carotid endarterectomy, thrombolytics, anticoagulant therapy, antiplatelet agents, neuroprotective agents, and treating associated risk factors such as hypertension and hyperlipemia. However, in spite of the significant development in these areas of stroke research, none of the available therapeutic options are curative in that they can reduce the burden of stroke. This article briefly summarizes the status of advances made in order to understand the neurobiology of stroke and provide insight into the therapeutic strategies that could be developed for the effective management of ischemic stroke.
中风,即脑部发作,是由于大脑特定区域的血流中断所致,是主要的死亡原因。中风是发达国家第三大致死和致残原因。这一医学问题复杂的病理生理学包括兴奋性毒性机制、炎症途径、氧化损伤和离子失衡。最终结果是缺血性神经元死亡,导致神经元功能不可逆转的丧失。最近,在治疗方面取得了重大进展,包括使用颈动脉内膜切除术、溶栓剂、抗凝治疗、抗血小板药物、神经保护剂,以及治疗高血压和高脂血症等相关风险因素。然而,尽管在中风研究的这些领域取得了重大进展,但现有的治疗方法都无法治愈中风,即它们无法减轻中风的负担。本文简要总结了所取得的进展情况,以便了解中风的神经生物学,并深入探讨可为有效管理缺血性中风而制定的治疗策略。